Skip to content

Quick ratio at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.8×-0.3×
Stryker logo
StrykerSYK
1.3×+0.3×
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
1.8×+0.3×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
0.9×-0.5×
Globus Medical logo
Globus MedicalGMED
+0.2×
Alphatec Holdings logo
Alphatec HoldingsATEC
1.1×-0.5×

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
Enterprise value$61.89M-41.5%
P/E32.3×
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Calculated from Xtant Medical Holdings’s reported figures.

Based on the most recent quarter.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's quick ratio?
Xtant Medical Holdings (XTNT) reported quick ratio of 1.6× in Q1 2026.
How has Xtant Medical Holdings's quick ratio changed year-over-year?
Xtant Medical Holdings's quick ratio increased by 59.7% year-over-year, from 1× to 1.6×.
What is the long-term trend for Xtant Medical Holdings's quick ratio?
Over 5 years (2020 to 2025), Xtant Medical Holdings's quick ratio has grown at a 33.2% compound annual growth rate (CAGR), from 0.4× to 1.6×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.